X-gen Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for X-GEN PHARMS INC, and what generic and branded alternatives to X-GEN PHARMS INC drugs are available?
X-GEN PHARMS INC has one approved drug.
Drugs and US Patents for X-gen Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
X-gen Pharms Inc | PENTAMIDINE ISETHIONATE | pentamidine isethionate | FOR SOLUTION;INHALATION | 206983-001 | Jan 20, 2023 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.